Agios to Present at the Citi 14th Annual Biotech Conference on Thursday, September 5, 2019
August 29 2019 - 4:05PM
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of
cellular metabolism to treat cancer and rare genetic diseases,
today announced that the company is scheduled to present at the
Citi 14th Annual Biotech Conference in Boston on Thursday,
September 5, 2019 at 12:00 p.m. ET.
A live webcast of the presentation can be accessed under "Events
& Presentations" in the Investors section of the company's
website at www.agios.com. A replay of the webcast will be archived
on the Agios website for at least two weeks following the
presentation.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat cancer and rare
genetic diseases through scientific leadership in the field of
cellular metabolism and adjacent areas of biology. In addition to
an active research and discovery pipeline across both therapeutic
areas, Agios has two approved oncology precision medicines and
multiple first-in-class investigational therapies in clinical
and/or preclinical development. All Agios programs focus on
genetically identified patient populations, leveraging our
knowledge of metabolism, biology and genomics. For more
information, please visit the company's website
at www.agios.com.
Investor & Media Contact:Holly Manning,
617-844-6630Associate Director, Investor
RelationsHolly.Manning@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Apr 2023 to Apr 2024